AARTIPHARMNSEAarti Pharmalabs LimitedMinimalNeutral
Announced Wed, 27 May · 12:24 IST

Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

AARTIPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.9%1-day move
₹694.65
prior close
₹661.05
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.0+0.2-0.1-6.9-7.6-8.4-10.5-7.6-12.5-5.1-2.4-1.7
Up moveDown movePending
AI summary

Aarti Pharmalabs has submitted copies of newspaper publications containing its standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. The results were published in Financial Express (English) and Loksatta-Jansatta (Gujarati) on May 27, 2026. This filing is in compliance with SEBI Listing Regulations (Regulation 30 and Regulation 47). The actual financial numbers are not visible in the enclosed newspaper clippings due to formatting issues. The filing was signed by Jeevan Mondkar, Company Secretary and Legal Head.

Likely market impact

This is a routine regulatory compliance filing indicating the company has published its annual audited financial results in newspapers as mandated. No immediate stock impact expected - investors should refer to the official stock exchange filings or company website for actual financial numbers.